Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Minoru Okuda"'
Publikováno v:
Allergology International, Vol 53, Iss 3, Pp 245-254 (2004)
Background: The aim of the present survey was to investigate the changes associated with fexofenadine administration in the quality of life (QOL) of Japanese cedar pollinosis patients. Methods: After obtaining informed consent, volunteers suffering f
Externí odkaz:
https://doaj.org/article/c71e7192060d4603a24bbf4f3c155778
Publikováno v:
Allergology International, Vol 52, Iss 4, Pp 207-212 (2003)
Background: In allergic rhinitis, antigen-antibody reactions occur in the nasal mucosa through antigen exposure. A strong reaction occurs following exposure to a large amount of antigen, whereas no reaction occurs in the absence of antigens. In seaso
Externí odkaz:
https://doaj.org/article/be69d5c8b640406c89a869ae5834f6a9
Autor:
Minoru Okuda, Takao Shida
Publikováno v:
Allergology International, Vol 47, Iss 1, Pp 1-8 (1998)
Japanese cedar pollinosis (JCPsis) is a major national health problem in Japan. The present review provides an update on information on JCPsis based on clinical data from our research group, through the support of the Department of Health and Welfare
Externí odkaz:
https://doaj.org/article/6cdafae8431e4957ab65bbc83d846a61
Autor:
Kimihiro Okubo, Minoru Okuda
Publikováno v:
Allergology International, Vol 47, Iss 3, Pp 225-232 (1998)
The definition of late-phase response (LPR) associated with nasal allergy is not as clear as that associated with asthma. Furthermore, LPR and immediate-phase response often act in concert to produce confounding symptoms due to repeated attacks over
Externí odkaz:
https://doaj.org/article/c1b662a39adf419086dba1e908e773bd
Autor:
Kimihiro Okubo, Minoru Gotoh, Yoshitaka Okamoto, Shigetoshi Horiguchi, Shuji Yonekura, Minoru Okuda, A. Konno
Publikováno v:
Clinical & Experimental Allergy Reviews. 12:10-16
Summary It is considered that early intervention for pollinosis relieves symptoms during the pollen season in Japan. Therefore, initiating medication prior to pollen dispersal has recently become a popular trend under the influence of the mass media.
Autor:
Minoru Okuda
Publikováno v:
Practica Oto-Rhino-Laryngologica. 103:85-98
Dexamethasone cipecilate (NS-126C), a new steroid nasal spray in powder form, is effective in once-a-day administration. We conducted a placebo-controlled, double-blind phase I clinical study in single administration at 50 μg, 100 μg, 200 μg, or 4
Publikováno v:
Practica oto-rhino-laryngologica. Suppl.. 125:1-17
Publikováno v:
Practica oto-rhino-laryngologica. Suppl.. 127:1-16
A 2-week randomized double-blind parallel-group comparison study of dexamethasone cipecilate (NS-126C) was conducted to verify efficacy at 400 μg/day QD in these with perennial allergic rhinitis versus fluticasone propionate (FP) nasal solution at 2
Autor:
Minoru Okuda
Publikováno v:
Practica Oto-Rhino-Laryngologica. 103:277-286
Publikováno v:
Practica Oto-Rhino-Laryngologica. 103:489-502
A placebo-controlled randomized double-blind parallel-group comparison study of dexamethasone cipecilate (NS-126C) steroid nasal spray, conducted in those with perennial allergic rhinitis, clarified efficacy and safety of drug administration at 400